International Medical Center of Biomaterials Processing and Cryostorage (MOEX:GEMA)

Market Cap	10.03B
Revenue (ttm)	376.74M +8.1%
Net Income	158.39M +4.7%
EPS	10.61 +4.7%
Shares Out	14.93M
PE Ratio	63.34
Forward PE	n/a
Dividend	8.65 (1.29%)
Ex-Dividend Date	n/a

Volume	90
Average Volume	778
Open	666.00
Previous Close	673.50
Day's Range	666.00 - 674.00
52-Week Range	601.00 - 1,250.00
Beta	0.12
RSI	38.85
Earnings Date	Mar 20, 2026

About MOEX:GEMA

International Medical Center of Biomaterials Processing and Cryostorage Public Joint-stock company operates as a personal stem cell storage bank in Russia. The company is also involved in the development of drugs for the treatment of blood and immune system diseases. It stores biomaterial samples, including samples of hematopoietic cord blood stem cells, as well as samples of mesenchymal stem cells and umbilical cord tissue for transplant. The company was founded in 2003 and is based in Moscow, Russia. International Medical Center of Biomateria...

• Industry: Miscellaneous Health And Allied Services, Not Elsewhere Classified
• Founded: 2003
• Employees: 15
• Stock Exchange: Moscow Stock Exchange
• Ticker Symbol: GEMA

Financial Performance

In 2025, MOEX:GEMA's revenue was 376.74 million, an increase of 8.07% compared to the previous year's 348.60 million. Earnings were 158.39 million, an increase of 4.74%.